Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-05

Clinical Trial Update: The Use of Cyproheptadine in Pediatric Feeding Disorders [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on the use of cyproheptadine for pediatric feeding disorders; study is ongoing but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cyproheptadine (cyproheptadine)

Snippet

Sponsor: University of Miami | Conditions: Pediatric Feeding Disorder, Chronic, Avoidant Restrictive Food Intake Disorder | Phase 4 | Status: ACTIVE_NOT_RECRUITING